Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction

Experimental Neurology
Cinzia CostaFrancesco Pisani

Abstract

Since the anti-epileptic drug Zonisamide (ZNS) seems to exert beneficial effects in Parkinson's (PD) disease, we have investigated the electrophysiological effects of ZNS in a rat corticostriatal slice preparation. ZNS affected neither the resting membrane potential nor the input resistance of the putative striatal spiny neurons. In contrast, this drug depressed in a dose-dependent manner the current-evoked repetitive firing discharge with a EC(50) value of 16.38 microM. ZNS also reduced the amplitude of glutamatergic excitatory postsynaptic potentials (EPSPs) with a EC(50) value of 32.5 microM. Reduced activity of the mitochondrial respiratory chain, particularly complex I and II, is implicated in the pathophysiology of PD and Huntington's (HD) diseases, respectively. Thus, ZNS was also tested in two different in vitro neurotoxic models obtained by acutely exposing corticostriatal slices either to rotenone, a selective inhibitor of mitochondrial complex I, or to 3-nitropropionic acid (3-NP), an inhibitor of complex II. Additionally, we also investigated the effect of ZNS in an in vitro model of brain ischemia. Interestingly, low concentrations of ZNS (0.3, 1, 3 and 10 microM) significantly reduced the rotenone-induced toxicity...Continue Reading

References

Oct 1, 1992·Current Opinion in Neurobiology·M F Beal
Aug 1, 1986·Annals of Neurology·Y YaariJ H Pincus
Jun 9, 1987·Brain Research·C L Schauf
Jun 1, 1996·Seizure : the Journal of the British Epilepsy Association·M KitoK Watanabe
Apr 1, 1996·Progress in Neurobiology·J G Greene, J T Greenamyre
Dec 1, 1995·Current Opinion in Neurology·E Brouillet, P Hantraye
Nov 1, 1995·Epilepsy Research·M OkadaY Fukushima
May 26, 1998·Epilepsy Research·A MoriL Packer
Aug 26, 1998·Biochimica Et Biophysica Acta·M F Beal
Sep 28, 1998·Annals of Neurology·A H SchapiraJ M Cooper
Oct 9, 1999·Progress in Neurobiology·E BrouilletP Hantraye
Jan 5, 2000·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·G W KimP H Chan
Mar 4, 2000·Stroke; a Journal of Cerebral Circulation·P CalabresiG Bernardi
Mar 23, 2000·Progress in Neurobiology·P CalabresiG Bernardi
Oct 29, 2000·Trends in Neurosciences·T N Chase, J D Oh
Nov 9, 2000·Journal of Neurophysiology·R C FoehringD J Surmeier
Dec 2, 2000·Nature Neuroscience·R BetarbetJ T Greenamyre
Feb 15, 2001·Experimental Neurology·D S AlbersM F Beal
Feb 19, 2002·Neurochemistry International·David S Albers, M Flint Beal
Sep 17, 2002·Brain Research·Jason W ChirichignoDavid S Albers
Feb 1, 2003·Journal of Neurochemistry·Günter U HöglingerEtienne C Hirsch
Apr 1, 2003·Nature Neuroscience·Barbara PicconiPaolo Calabresi
Jun 5, 2003·Annals of Neurology·Paolo CalabresiGiorgio Bernardi
Sep 3, 2003·Journal of Neurochemistry·Yi HeWeidong Le
Jan 17, 2004·Stroke; a Journal of Cerebral Circulation·Cinzia CostaPaolo Calabresi

❮ Previous
Next ❯

Citations

Dec 19, 2013·Indian Journal of Pharmacology·Neeta D GroverTatyasaheb R Patil
Mar 4, 2010·Rinshō shinkeigaku = Clinical neurology·Miho Murata
Oct 22, 2013·Neurochemical Research·Salvatore CondelloFrancesco Pisani
Dec 14, 2011·Expert Opinion on Drug Metabolism & Toxicology·Josef Finsterer, Sinda Zarrouk Mahjoub
Jun 5, 2012·European Journal of Pharmacology·M E ChoudhuryM Nomoto
May 11, 2010·Experimental Neurology·Thomas W RöslerGünter U Höglinger
Feb 16, 2011·Brain Research·Mohammed Emamussalehin ChoudhuryMasahiro Nomoto
Jan 8, 2021·Frontiers in Neuroscience·Chengqian LiAnmu Xie
May 13, 2021·Drug Design, Development and Therapy·Babak Tousi, James B Leverenz
Aug 28, 2021·International Journal of Molecular Sciences·Kaneyasu Nishimura, Kazuyuki Takata

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.